ORAL PRESENTATIONS

Session 1: Through the Looking Glass: Future Needs in HIV
Treatment and Prevention

Session 2: Parallel oral abstract sessions

CLINICAL & SOCIOBEHAVIOURAL SCIENCE

Johann Kolstee – Discontinuing PrEP, why and what next? – An exploration of why European MSM stop taking PrEP, how they continue to protect themselves from HIV and who is being left behind

Haoyi Wang – Applying structural topic modelling based on machine learning to empower qualitative research: Perceptions of long-acting injectable PrEP among MSM in the Netherlands and Belgium based on Dutch open-ended responses

Jolanda Voermans – Development, validation, and real-world implementation of a rapid diagnostic assay for the screening of non-suppressible viremia in people with HIV-1

Maaike Kok – Nurse-directed sameday initiation of cART: high feasibility and more rapid virologic control using a uniform algorithm

Manon Vanbellinghen – People with HIV with major ECG abnormalities have a significantly higher risk of incident CVD compared to people without HIV

Anke Bruns – Incidence of community-acquired pneumonia and herpes zoster in people with HIV based on CD4-count and age in the current antiretroviral therapy era: a longitudinal cohort study

EPIDEMIOLOGY & PUBLIC HEALTH

Alexandra Teslya – Evaluating the impact and effectiveness of HIV testing strategies among men who have sex with men in the Netherlands

Alexandra de Nooy – Identifying where HIV self-screening yields the greatest impact: insights from routine data in South Africa

Carien Blomaard – Changes in condomless anal sex and HIV and STI incidence among men who have sex with men over a period of 15 years: findings from the prospective Amsterdam Cohort Studies

Jacob Roberts – Reconstructing the 2022 mpox outbreak among MSM in the Netherlands: Insights into transmission dynamics by HIV status

BASIC & TRANSLATIONAL SCIENCE

Suzanne Ruijten – HIV-Associated Sex Differences in the Plasma Proteome Associate with Reservoir Size and CVD risk

Anniek Tanja – Latency Promoting Agents as Experimental Tools and Block-and-Lock Candidates in HIV Cure Research

Florence Stel – Comparing a Nanobody-Based Anti-Capsid Biological and Lenacapavir as Intracellular Capsid Inhibitors to Block HIV-1 Replication

Session 3: Paradigm Shifts and Breakthroughs in HIV science

No presentations available 

Session 4: NCHIV 2025’s Top Science in a Changing Political Landscape

NCHIV is organised by